Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Guido Arcaro"'
Autor:
Filippo Valbusa, Andrea Angheben, Alessandro Mantovani, Verena Zerbato, Andrea Chiampan, Stefano Bonapace, Paola Rodari, Davide Agnoletti, Guido Arcaro, Cristiano Fava, Zeno Bisoffi, Giovanni Targher
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220689 (2019)
An ever-increasing number of patients with chronic indeterminate Chagas disease are diagnosed with early vascular and cardiac abnormalities, as cardiovascular imaging becomes more sensitive. However, the currently available information on aortic stif
Externí odkaz:
https://doaj.org/article/33ff22d1e2164607b742600a68f3841b
Autor:
Davide Agnoletti, Guido Arcaro, Giuliana Scaturro, Emanuela Turcato, Elisa Grison, Elena Ferrari, Stefano Bonapace, Giovanni Targher, Filippo Valbusa
Publikováno v:
Internal and Emergency Medicine.
Background Heart failure (HF) is a major cause of death among the elderly. Its prevalence increases dramatically with age. The prevalence of malnourished subjects is high in hospitalized elderly patients. We aimed to investigate the prognostic role o
Autor:
Filippo Valbusa, Andrea Angheben, Verena Zerbato, Andrea Chiampan, Davide Agnoletti, Cristiano Fava, Zeno Bisoffi, Guido Arcaro
Publikováno v:
Artery Research, Vol 20 (2017)
Background: In Italy, the prevalence of seropositivity for Trypanosoma cruzi in immigrants from endemic countries is about 11.3% (30.7% for Bolivian immigrants). The disease acute phase is usually asymptomatic, often leading to chronic infection tha
Externí odkaz:
https://doaj.org/article/f48a4f1bc8704468b7381ebc0dd63522
Autor:
Filippo Valbusa, Stefano Bonapace, Davide Agnoletti, Luca Scala, Cristina Grillo, Pietro Arduini, Emanuela Turcato, Alessandro Mantovani, Giacomo Zoppini, Guido Arcaro, Christopher Byrne, Giovanni Targher
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173398 (2017)
Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for heart failure (HF). Although some progress has been made in improving survival among patients admitted for HF, the rates of hospital readmissions and the related costs continue t
Externí odkaz:
https://doaj.org/article/d23c3233db194b1e99efa824e9a1637e
Publikováno v:
Artery Research, Vol 16 (2016)
Background: Diabetic hypertensives patients present different hemodynamic pattern than only hypertensive patients. We aimed to investigate the relationship between the diastolic function and the pulse pressure amplification (PPA), an index combining
Externí odkaz:
https://doaj.org/article/c7a0f7ade4964ccd98b416fff27c092b
Autor:
Alessandro Inno, Lorenzo Belluomini, Stefania Gori, Guido Arcaro, Paolo Bocus, Antonio Russo, Zeno Bisoffi
Publikováno v:
Critical Reviews in Oncology/Hematology. 143:139-147
Gut microbiota is involved in gastrointestinal carcinogenesis. Also, it modulates the activity, efficacy and toxicity of several chemotherapy agents, such as gemcitabine, cyclophosphamide, irinotecan, cisplatin and 5-Fluorouracil, and target therapy,
Autor:
Andrea Chiampan, Giovanni Targher, Guido Arcaro, Alessandro Mantovani, Davide Agnoletti, Paola Rodari, Verena Zerbato, Stefano Bonapace, Filippo Valbusa, Andrea Angheben, Zeno Bisoffi, Cristiano Fava
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0220689 (2019)
PLoS ONE, Vol 14, Iss 8, p e0220689 (2019)
An ever-increasing number of patients with chronic indeterminate Chagas disease are diagnosed with early vascular and cardiac abnormalities, as cardiovascular imaging becomes more sensitive. However, the currently available information on aortic stif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2866abafb17307c1e2a26dc61502e69
http://hdl.handle.net/11562/999241
http://hdl.handle.net/11562/999241
Autor:
Davide Agnoletti, Giovanni Targher, Pietro Arduini, Aldo P. Maggioni, Giuliana Scaturro, Filippo Valbusa, Giacomo Zoppini, Alessandro Mantovani, Stefano Calabria, Stefano Bonapace, Luca Scala, Cristina Grillo, Emanuela Turcato, Guido Arcaro
Background: Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for incident heart failure (HF). It is currently unknown whether NAFLD predicts all-cause mortality in patients admitted for acute HF. We aimed to assess whether NAFLD an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e234c4b6bd0be39feb29d1653cbe3c4
http://hdl.handle.net/11585/863916
http://hdl.handle.net/11585/863916
Autor:
Giovanni Targher, Cristina Grillo, Giacomo Zoppini, Pietro Arduini, Filippo Valbusa, Emanuela Turcato, Alessandro Mantovani, Guido Arcaro, Christopher D. Byrne, Davide Agnoletti, Stefano Bonapace, Luca Scala
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173398 (2017)
PLoS ONE
PLoS ONE
Nonalcoholic fatty liver disease (NAFLD) is an emerging risk factor for heart failure (HF). Although some progress has been made in improving survival among patients admitted for HF, the rates of hospital readmissions and the related costs continue t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40a3c92efe0dc57ac24d77eb2cc6f23
https://eprints.soton.ac.uk/406198/
https://eprints.soton.ac.uk/406198/
Autor:
Stefano Bonapace, Guido Arcaro, Luciano Zenari, Lorenzo Bertolini, Giacomo Zoppini, Giovanni Targher, Filippo Valbusa, Christopher D. Byrne
Publikováno v:
The American Journal of Cardiology. 112:499-504
The association between serum uric acid (SUA) levels and atrial fibrillation (AF) is currently poorly known. We examined the association between SUA levels and risk of incident AF in patients with type 2 diabetes mellitus. We followed for 10 years a